Skip to main content
OpenTrials

Clinical trial condition

Histiocytosis, Langerhans-Cell

Explore clinical trials studying Histiocytosis, Langerhans-Cell. Study availability and eligibility vary by location and protocol.

62 public trials 20 recruiting studies
Refine in advanced search Browse all conditions

Histiocytosis, Langerhans-Cell trial results

Recruiting

A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis

NCT05828069

Conditions
Hemic and Lymphatic Diseases, Histiocytosis, Histiocytosis, Langerhans-Cell, +6 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Kaiser Permanente Downey Medical Center Downey, California, United States
  • Loma Linda University Medical Center Loma Linda, California, United States
View all 120 locations
View Trial Details
Recruiting

DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positive Cancers.

NCT07440290

Conditions
Adenocarcinoma, Adenocarcinoma, Papillary, Adnexal Diseases, +78 more
Locations
  • Belfast City Hospital Belfast, United Kingdom
  • University Hospital Birmingham Birmingham, United Kingdom
  • Birmingham Children's Hospital Birmingham, United Kingdom
  • Bristol Royal Hospital for Children Bristol, United Kingdom
View all 27 locations
View Trial Details
Recruiting

Modified LCH-III Regimen With or Without Luvometinib for Multisystem Pediatric Langerhans Cell Histiocytosis

NCT07431060

Conditions
Hemic and Lymphatic Diseases, Histiocytosis, Histiocytosis, Langerhans-Cell, +5 more
Locations
  • West China Second Hospital, Sichuan University Chengdu, China
  • Affiliated Hospital of Guizhou Medical University Guiyang, China
  • Anhui Provincial Children's Hospital Hefei, China
  • The Second Affiliated Hospital of Anhui Medical University Hefei, China
View Trial Details
Recruiting

Luvometinib in Pediatric SS-LCH With Special-site Single/Multifocal Bone Lesions

NCT07371182

Conditions
Hemic and Lymphatic Diseases, Histiocytosis, Histiocytosis, Langerhans-Cell, +5 more
Locations
  • The Second Affiliated Hospital of Anhui Medical University Hefei, Anhui, China
  • The Second Affiliated Hospital of Guangxi Medical University Nanning, Guangxi, China
  • Affiliated Hospital of Guizhou Medical University Guiyang, Guizhou, China
  • Zunyi Medical University Affiliated Hospital, Guizhou Provincial Children's Hospital Zunyi, Guizhou, China
View Trial Details

Related conditions